Enhanced myeloid differentiation factor 88 promotes tumor metastasis via induction of epithelial-mesenchymal transition in human hepatocellular carcinoma.
about
Myeloid differentiation primary response gene 88-leukotriene B4 receptor 2 cascade mediates lipopolysaccharide-potentiated invasiveness of breast cancer cellsDownregulation of adaptor protein MyD88 compromises the angiogenic potential of B16 murine melanoma.Predictive values of serum VEGF and CRP levels combined with contrast enhanced MRI in hepatocellular carcinoma patients after TACE.Clinical and pathological significance of myeloid differentiation factor 88 expression in human hepatocellular carcinoma tissues.The contribution of toll-like receptor signaling to the development of liver fibrosis and cancer in hepatocyte-specific TAK1-deleted mice.Hepatitis C Virus and Hepatocellular Carcinoma: Pathogenetic Mechanisms and Impact of Direct-Acting Antivirals.
P2860
Enhanced myeloid differentiation factor 88 promotes tumor metastasis via induction of epithelial-mesenchymal transition in human hepatocellular carcinoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 March 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Enhanced myeloid differentiati ...... uman hepatocellular carcinoma.
@en
Enhanced myeloid differentiati ...... uman hepatocellular carcinoma.
@nl
type
label
Enhanced myeloid differentiati ...... uman hepatocellular carcinoma.
@en
Enhanced myeloid differentiati ...... uman hepatocellular carcinoma.
@nl
prefLabel
Enhanced myeloid differentiati ...... uman hepatocellular carcinoma.
@en
Enhanced myeloid differentiati ...... uman hepatocellular carcinoma.
@nl
P2093
P2860
P356
P1476
Enhanced myeloid differentiati ...... uman hepatocellular carcinoma.
@en
P2093
P2860
P356
10.1038/CDDIS.2014.71
P577
2014-03-06T00:00:00Z